PJP: Big Pharma Concentration Risks Amid Looming Confirmation Of RFK Jr.
This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, ...
Stryker Corporation: A Wide-Moat Medical Device Company, But Overvalued
Stryker Corporation's growth strategy includes acquisitions, but high debt levels and goodwill present challenges, making ...